- Tytuł:
- Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology June 2017 18(6):755-769
Czasopismo naukowe